ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
Avatar

Single-molecule Sequencing Reveals Patterns of Pre-existing Drug Resistance that Suggest Treatment Strategies in Philadelphia-positive Leukemias

By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Justin Pritchard
By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Justin Pritchard
0 views
December 3, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Recommended

AUTOPLAY
08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
06:00
2024 Clinical Case Studies

Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration

Feat. A. Geisler
15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
06:51
Insights from 2023 ASH Annual Meeting

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Feat. D. Tremblay
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
37:12
Tisch Cancer Institute at Mount Sinai

Leukemia Tumor Board at the Tisch Cancer Institute at Mount Sinai: 6…

Feat. M. Metzger
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in ALL

Feat. B. Shah
25:01
Indy Hematology Review

Review of Emerging Therapies and Top Trials in Hematologic Malignanc…

Feat. R. Birhiray
20:32
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis …

Feat. S. Kalayoglu Besisik
08:04
2nd SOHO Italian Conference

Cell Morphology in Acute Leukemias & Hematologic Malignancies: D…

Feat. G. Zini
13:54
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on Asparaginase-Related Toxicity in AYAs With ALL: …

Feat. K. Schmiegelow
23:01
Indy Hematology Review

Improvements in Treating Ph-like ALL, Trials in Pre B-ALL & Blin…

Feat. H. Kantarjian
22:07
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

How to Identify and Manage Ph-like ALL

Feat. S. Tasian
22:50
UNMC Leukemia Symposium: Focus on Opportunities to Improve Care

Palliative vs. Hospice Care & Benefits of Early Integration of P…

Feat. M. Teply
03:47
Indy Hematology Review

Challenging Cases in Leukemia: AML & ALL

Feat. M. Wiemann
08:18
Penn Medicine Abramson Cancer Center

The Making of the Tisagenlecleucel CAR T

Feat. C. June
43:39
Leonard Calabrese

T-cell Activation, Deactivation and Control and the Impact of Cancer…